Leaders from the Science and Technology Department of China’s Ministry of Industry and Information Technology visited Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shisi Pharmaceutical Group, for a research visit.
Category:
Time:2020-03-12
【概要描述】
On March 10, Bi Kaichun, a first-level inspector with the Science and Technology Department of the Ministry of Industry and Information Technology, and head of the 10th Special Task Force of the Medical Supplies Guarantee Group under the State Council’s Joint Prevention and Control Mechanism for the Novel Coronavirus Pneumonia Epidemic, along with members of the Standing Committee of the Cangzhou Municipal Party Committee and the Party Secretary of the Bohai New Area, ...
On March 10, Bi Kaichun, a first-level inspector with the Science and Technology Department of the Ministry of Industry and Information Technology and head of the 10th team of special envoys stationed at enterprises under the Medical Supplies Guarantee Group of the State Council’s Joint Prevention and Control Mechanism for the Novel Coronavirus Pneumonia Epidemic, visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group, accompanied by Zhang Guodong, a member of the Standing Committee of the Cangzhou Municipal Party Committee, Secretary of the Party Working Committee and Director of the Management Committee of Bohai New Area, and also head of the Leading Group for COVID-19 Prevention and Control in Bohai New Area.
▲ Bi Kaichun (third from left in the front row), First-Level Inspector of the Science and Technology Department of the Ministry of Industry and Information Technology, and Head of the 10th Team of Special Representatives Stationed at Enterprises under the Medical Supplies Guarantee Group of the Joint Prevention and Control Mechanism of the State Council for the Prevention and Control of the Novel Coronavirus Pneumonia Epidemic, visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group for a research visit.
Bi Kaichun had an in-depth discussion with Gao Shuping, Chairwoman of Hebei Guangxiang Pharmaceutical, to learn about the implementation of the company’s epidemic prevention and control measures as well as its resumption of production and operations. Bi Kaichun fully affirmed the company’s achievements in epidemic prevention and control and in promoting economic and social development. He encouraged the company to continue regarding innovation as the primary driving force behind its development, constantly improving quality and efficiency, emphasizing scientific and technological research and development as well as the commercialization of scientific and technological achievements, actively exploring the construction of industrial internet platforms, and continuously enhancing the company’s innovation capacity and competitiveness.
Gao Shuping stated that they will continue to rigorously implement all prevention and control measures and fully promote the resumption of production and attainment of desired results. At the same time, they will intensify efforts in scientific and technological innovation, expand and strengthen enterprises, and make greater contributions to advancing the development of the coastal economic belt.
Relevant officials from the Cangzhou Bohai New Area accompanied the inspection.
Keywords:
Recommended
SERVICE HOTLINE
Zip Code: 052165
Address: No.9 Xingye Street, Gaocheng District, Shijiazhuang City, Hebei Province
Mobile site
E code
Business license